Monday, August 18, 2008

Positive CIMZIA results from pivotal PHASE III Crohn's disease trial at major US medical meeting, UCB Part 3




About Crohn's Disease Crohn's contamination be a incurable anarchy that cause inflammation of the gastrointestinal tract, most advantageous widely at the run out of the negligible intestine (the ileum) and the set of laws of the generous intestine (the colon). Common symptom cover diarrhea, restiveness, abdominal misery and counterweight injury. Although it can turn out at any age, it predominantly impact immature adults relating the ages of 15 and 35. Because it is a chronic illness, patients feel an ongoing cycle of symptom "flare-ups" and period of remission, when symptoms peter out or be controlled.1 This cycle can impact all aspect of a patient's existence, with their pursuit of elevated rearing and interaction effective employer, friends and kindred.



About Cimzia Cimzia is one-off anti-TNF psychiatric therapy within that it is a humanize antibody Fab' shred chemically attached to polyethylene glycol (PEG, i.e. PEGylated). PEGylation reproduction the plasma half-life of certolizumab to say two weeks.



About UCB UCB (www.bestdrugsnow.com) is a intercontinental biopharmaceutical leading light faithful to the research, advancement and commercialization of advanced products in the paddock of centralized faint-hearted system disorder, allergy and respiratory disease, immune and inflammatory disorders and oncology. UCB employ complete 8,500 kin operating in over 40 country, and get done revenues of 2.1 billion (including web turnover, monarchs, and fees) in 2004. UCB is programmed on head of the Euronext Brussels with a souk capitalization of approximately 5.5 billion. Worldwide headquarters are sited in Brussels, Belgium.



UCB Pharma, Inc. is the North American subsidiary of UCB, with U.S. headquarters located in Smyrna, Georgia. UCB's knob products in the U.S. are Keppra (levetiracetam), Zyrtec (cetirizine HCl), Tussionex CIII (hydrocodone polistirex/chlorpheniramine polistirex), and Metadate CD CII (methylphenidate HCl, USP).



Zyrtec is licensed to and co-promoted with Pfizer, Inc. in the United States.



"We also hope the pills industry will nominate yourself more aggressively on price when consumers commence to migrate to effective and out of danger drugs that are also more affordable," Gurin added.



2. European Federation of Crohn's & Ulcerative Colitis Associations. Newsletter, pg. 30, May 2005 (www.bestdrugsnow.com).



3. Crohn's and Colitis Foundation of America and the Digestive Disease National Coalition. Voices of Crohn's Survey: www.bestdrugsnow.com Accessed September 22, 2005.



Susan Thiele Ketchum



Press to learn here more shipping policy



No comments: